 A retrospective study found that the relative protection against SARS-CoV-2 infection from mRNA vaccines decreases from 53.4% to 16.5% three months after vaccination, indicating a significant decline in vaccine effectiveness against the Armacran variant. This article was authored by Tal Patalan, Yaki Seishuk, Asof Peretz, and others.